Country for PR: Hong Kong
Contributor: PR Newswire Asia (Hong Kong)
Thursday, April 28 2022 - 10:15
AsiaNet
HealthBeats Raises US$3m Seed Funding Led By Heritas Capital And SEEDS Capital To Expand Remote Vitals Monitoring In Australia And Singapore
SINGAPORE and SYDNEY and NEW YORK, April 28, 2022 /PRNewswire-AsiaNet/ --

HealthBeats(TM), a Singapore-based healthtech start-up with end-to-end remote 
vitals monitoring solution, today announced the close of a US$3m Seed round led 
by healthcare investor Heritas Capital together with SEEDS Capital, the 
investment arm of government agency Enterprise Singapore.

The HealthBeats(TM) Remote Vitals Monitoring platform provides healthcare 
providers and patients with a simple-to-use and simple-to-deploy solution to 
remotely monitor patients at home using clinical-grade medical devices. The 
user-friendly platform supports a wide range of diseases using regulatory 
approved devices from multiple brands, and covering various vitals such as 
temperature, blood oxygen saturation, blood pressure, blood glucose, body 
weight and more. Vitals are transmitted real-time to healthcare providers for 
proactive care management.

According to a large-scale Commonwealth Scientific and Industrial Research 
Organisation (CSIRO) telehealth study funded by the Australian government, 
remote monitoring of chronic diseases has the potential to save up to A$3 
billion a year through reduction of avoidable admission by 53.2% and reduction 
in rate of length of stay by 75.7%. Australian healthcare providers have also 
demonstrated positive clinical outcomes from the deployment of HealthBeats 
Remote Vitals Monitoring solution with some of them reporting reductions in 
avoidable hospital admissions by up to 50%. The HealthBeats platform has also 
defied common belief that elderly chronic patients are less technological savvy 
with the largest pool of patients being aged 61 and above, with those aged 81 
and above achieving the highest adherence even after 6 months.

HealthBeats has deployed its Remote Vitals Monitoring solution to 30 hospitals 
and clinics across Australia, working with various Primary Health Networks 
(PHNs) and Local Health Districts (LHDs) supporting various use cases such as 
chronic disease management, post-hospitalisation, emergency response for 
Covid-19 and clinical trials.  

"At HealthBeats, we believe that regular monitoring both within and outside of 
institutional healthcare settings can only lead to better outcomes. We aim to 
work through the healthcare industry's inherent complexities to offer simple 
solutions and remain the platform of choice by healthcare providers and 
patients alike. We are fortunate to post positive cashflow and profitability by 
third year of our operations in 2021, made possible from strong trust and 
support from our customers, partners and most importantly, our team members. 
This Seed funding round will help boost our current strong growth momentum as 
we continue to deliver stellar value to our stakeholders through the 
acceleration of our product development and business development efforts," said 
Ms. Aileen Lai, CEO and Founder of HealthBeats. "We are excited to embark on 
our next stage of growth in partnership with Heritas Capital & SEEDS Capital."

"Heritas Capital invests in high-impact ventures across the healthcare space, 
especially tech-enabled solutions that are scalable in addressing underserved 
needs. The COVID-19 pandemic has created the urgent need to support our 
healthcare professionals and caregivers effectively with fit-for-purpose tools 
for enabling alternate sites-of-care especially in hospital-home community 
settings. We envision that HealthBeats is well-positioned to enhance and 
deliver a best-in-class remote patient monitoring platform as an integral part 
of value-based healthcare infrastructure beyond the pandemic," said Ms. Janet 
Chia, Principal and Head of Venture Capital at Heritas Capital.

"The solutions provided by homegrown startup HealthBeats are designed to meet 
the growing demand for remote monitoring solutions and gradual shift from 
provider to patient-centric solutions in today's healthcare climate. SEEDS 
Capital is delighted to partner Heritas Capital to support HealthBeats in 
building the platform's core capabilities and expanding the use of its solution 
across markets. Beyond assisting the company in enhancing its technology 
through further R&D in Singapore, we look forward to supporting HealthBeats as 
it strengthens its foothold in Australia and expands into new markets like the 
United States," said Tan Kaixin, General Manager of SEEDS Capital.

About HealthBeats

HealthBeats(TM) is a global Remote Vitals Monitoring platform designed to bring 
healthcare home. We provide patients with medical devices from multiple brands 
to be self-administered regularly at home and have their results transmitted 
real-time to their healthcare providers for proactive care management.

We build HealthBeats based on our belief that regular monitoring outside of 
healthcare settings can only lead to better outcomes. Through our collective 
and extensive experiences across the healthcare industry, we endeavour to work 
through the inherent complexities to bring simple solutions to patients and 
healthcare providers alike. HealthBeats is all about simplicity.

About Heritas Capital

Heritas Capital is a Singapore-based private equity and venture capital 
investment firm that invests in fast-growing companies and leading funds across 
the healthcare, education and technology sectors. Guided by our investment 
philosophy, "Invest with Purpose, Impact Across Generations", Heritas Capital 
backs innovative companies to become emerging champions and drive inclusive 
growth that improves the lives of local communities while delivering 
sustainable returns to investors.

About SEEDS Capital

As the investment arm of Enterprise Singapore, SEEDS Capital catalyses smart 
investments into innovative Singapore-based early-stage startups with strong 
intellectual content and global market potential. We adopt a co-investment 
model, working hand in hand with institutional investors from around the world. 
Leveraging our collective expertise and networks, we help startups 
commercialise, realise their business development plans and expand globally. We 
focus our investments into emerging and strategic sectors aligned with national 
priorities, including Manufacturing, Trade & Connectivity, Human Health & 
Potential, Urban Solutions & Sustainability, and Smart Nation & Digital Economy.

Source: HealthBeats